Mouse models of psoriasis

Journal of Investigative Dermatology

Volumn 127, Issue 6, 2007, Pages 1292-1308

  Gudjonsson, Johann E ^a,c   Johnston, Andrew ^b   Dyson, Melissa ^c   Valdimarsson, Helgi ^b   Elder, James T ^a,d  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c UNIVERSITY OF MICHIGAN   (United States)

^d VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; INTERLEUKIN 1ALPHA; STAT3 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

CALCIUM CELL LEVEL; CELLULAR IMMUNITY; GENETIC ENGINEERING; HOMOZYGOSITY; HYPERPLASIA; KERATINOCYTE; NONHUMAN; PHARYNGITIS; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN INFLAMMATION; STREPTOCOCCUS; STREPTOCOCCUS INFECTION; T LYMPHOCYTE; TRANSGENIC MOUSE; XENOGRAFT;

ANIMALS; DISEASE MODELS, ANIMAL; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; PSORIASIS;

EID: 34248591664     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700807     Document Type: Review

References (188)

1. Ardavin C (2003) Origin, precursors and differentiation of mouse dendritic cells. Nat Rev Immunol 3:582-90
2. Bachmann MF, McKall-Faienza K, Schmits R, Bouchard D, Beach J, Speiser DE et al. (1997) Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity 7:549-57
3. Bagutti C, Speight PM, Watt FM (1998) Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. J Pathol 186:8-16
4. Baker BS, Lambert S, Powles AV, Valdimarsson H, Fry L (1988) Epidermal DR+T6- dendritic cells in inflammatory skin diseases. Acta Derm Venereol 68:209-17
5. Barker JN, Goodlad JR, Ross EL, Yu CC, Groves RW, MacDonald DM (1993) Increased epidermal cell proliferation in normal human skin in vivo following local administration of interferon-gamma. Am J Pathol 142:1091-7
6. Barker JN, Karabin GD, Stoof TJ, Sarma VJ, Dixit VM, Nickoloff BJ (1991) Detection of interferon-gamma mRNA in psoriatic epidermis by polymerase chain reaction. J Dermatol Sci 2:106-11
7. Bartoli M, Platt D, Lemtalsi T, Gu X, Brooks SE, Marrero MB et al. (2003) VEGF differentially activates STAT3 in microvascular endothelial cells. FASEB J 17:1562-4
8. Basset-Seguin N, Escot C, Moles JP, Blanchard JM, Kerai C, Guilhou JJ (1991) C-fos and c-jun proto-oncogene expression is decreased in psoriasis: an in situ quantitative analysis. J Invest Dermatol 97:672-8
9. Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD (1993) Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis. J Exp Med 178:1271-81
10. Behnam SM, Behnam SE, Koo JY (2005) Review of cyclosporine immuno-suppressive safety data in dermatology patients after two decades of use. J Drugs Dermatol 4:189-94
11. Berking C, Takemoto R, Binder RL, Hartman SM, Ruiter DJ, Gallagher PM et al. (2002) Photocarcinogenesis in human adult skin grafts. Carcinogenesis 23:181-7
12. Bhagavathula N, Nerusu KC, Fisher GJ, Liu G, Thakur AB, Gemmell L et al. (2005) Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice. Am J Pathol 166:1009-16
13. Blessing M, Schirmacher P, Kaiser S (1996) Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions. J Cell Biol 135:227-39
14. Blumberg H, Conklin D, Xu WF, Grossmann A, Brender T, Carollo S et al. (2001) Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104:9-19
15. Bowcock AM, Cookson WO (2004) The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum Mol Genet 13(Spec No 1):R43-55
16. Boyman O, Hefti HP, Conrad C, Nickoloff BJ, Suter M, Nestle FO (2004) Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J Exp Med 199:731-6
17. Breban M, Fernandez-Sueiro JL, Richardson JA, Hadavand RR, Maika SD, Hammer RE et al. (1996) T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J Immunol 156:794-803
18. Brown WR, Hardy MH (1988) A hypothesis on the cause of chronic epidermal hyperproliferation in asebia mice. Clin Exp Dermatol 13:74-7
19. Brown WR, Hardy MH (1989) Mast cells in asebia mouse skin. J Invest Dermatol 93:708
20. Bullard DC, Scharffetter-Kochanek K, McArthur MJ, Chosay JG, McBride ME, Montgomery CA et al. (1996) A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice. Proc Natl Acad Sci USA 93:2116-21
21. Carlos TM, Harlan JM (1994) Leukocyte-endothelial adhesion molecules. Blood 84:2068-101
22. Carroll JM, Crompton T, Seery JP, Watt FM (1997) Transgenic mice expressing IFN-gamma in the epidermis have eczema, hair hypopigmentation, and hair loss. J Invest Dermatol 108:412-22
23. Carroll JM, Romero MR, Watt FM (1995) Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell 83:957-68
24. Cheng J, Turksen K, Yu QC, Schreiber H, Teng M, Fuchs E (1992) Cachexia and graft-vs. host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice. Genes Dev 6:1444-56
25. Choi SE, Choi EY, Kim PH, Kim JH (1999) Involvement of protein kinase C and rho GTPase in the nuclear signalling pathway by transforming growth factor-beta1 in rat-2 fibroblast cells. Cell Signal 11:71-6
26. Christianson SW, Greiner DL, Hesselton RA, Leif JH, Wagar EJ, Schweitzer IB et al. (1997) Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice. J Immunol 158:3578-86
27. Chung E, Graves-Deal R, Franklin JL, Coffey RJ (2005) Differential effects of amphiregulin and TGF-alpha on the morphology of MDCK cells. Exp Cell Res 309:149-60
28. Cook PW, Brown JR, Cornell KA, Pittelkow MR (2004) Suprabasal expression of human amphiregulin in the epidermis of transgenic mice induces a severe, early-onset, psoriasis-like skin pathology: expression of amphiregulin in the basal epidermis is also associated with synovitis. Exp Dermatol 13:347-56
29. Cook PW, Mattox PA, Keeble WW, Pittelkow MR, Plowman GD, Shoyab M et al. (1991) A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin. Mol Cell Biol 11:2547-57
30. Cook PW, Piepkorn M, Clegg CH, Plowman GD, DeMay JM, Brown JR et al. (1997) Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. J Clin Invest 100:2286-94
31. Cooper KD, Hammerberg C, Baadsgaard O, Elder JT, Chan LS, Taylor RS et al. (1990) Interleukin-1 in human skin: dysregulation in psoriasis. J Invest Dermatol 95:24S-6S
32. Cox AJ, Watson W (1972) Histological variations in lesions of psoriasis. Arch Dermatol 106:503-6
33. Cui W, Fowlis DJ, Cousins FM, Duffie E, Bryson S, Balmain A et al. (1995) Concerted action of TGF-beta 1 and its type II receptor in control of epidermal homeostasis in transgenic mice. Genes Dev 9:945-55
34. D'Armiento J, DiColandrea T, Dalal SS, Okada Y, Huang MT, Conney AH et al. (1995) Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Mol Cell Biol 15:5732-9
35. Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW et al. (1994) Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180:1141-6
36. Djalilian AR, McGaughey D, Patel S, Seo EY, Yang C, Cheng J et al. (2006) Connexin 26 regulates epidermal barrier and wound remodeling and promotes psoriasiform response. J Clin Invest 116:1243-53
37. Doi H, Shibata MA, Kiyokane K, Otsuki Y (2003) Downregulation of TGFbeta isoforms and their receptors contributes to keratinocyte hyperproliferation in psoriasis vulgaris. J Dermatol Sci 33:7-16
38. Donoff RB, McLennan JE, Grillo HC (1971) Preparation and properties of collagenases from epithelium and mesenchyme of healing mammalian wounds. Biochim Biophys Acta 227:639-53
39. Elder JT, Fisher GJ, Lindquist PB, Bennett GL, Pittelkow MR, Coffey RJ Jr et al. (1989) Overexpression of transforming growth factor alpha in psoriatic epidermis. Science 243:811-4
40. Elder JT, Sartor CI, Boman DK, Benrazavi S, Fisher GJ, Pittelkow MR (1992) Interleukin-6 in psoriasis: expression and mitogenicity studies. Arch Dermatol Res 284:324-32
41. Eppig JT, Bult CJ, Kadin JA, Richardson JE, Blake JA, Anagnostopoulos A et al. (2005) The Mouse Genome Database (MGD): from genes to mice - a community resource for mouse biology. Nucleic Acids Res 33:D471-5
42. Ettehadi P, Greaves MW, Wallach D, Aderka D, Camp RD (1994) Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions. Clin Exp Immunol 96:146-51
43. Fantini F, Magnoni C, Bracci-Laudiero L, Pincelli CT (1995) Nerve growth factor is increased in psoriatic skin. J Invest Dermatol 105:854-5
44. Fierlbeck G, Rassner G, Muller C (1990) Psoriasis induced at the injection site of recombinant interferon gamma. Results of immunohistologic investigations. Arch Dermatol 126:351-5
45. Fowlis DJ, Cui W, Johnson SA, Balmain A, Akhurst RJ (1996) Altered epidermal cell growth control in vivo by inducible expression of transforming growth factor beta 1 in the skin of transgenic mice. Cell Growth Differ 7:679-87
46. Fraki JE, Briggaman RA, Lazarus GS (1982) Uninvolved skin from psoriatic patients develops signs of involved psoriatic skin after being grafted onto nude mice. Science 215:685-7
47. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, Werner S (1995) Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 270:12607-13
48. Frank S, Stallmeyer B, Kampfer H, Kolb N, Pfeilschifter J (2000) Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair. J Clin Invest 106:501-9
49. Gates AH, Karasek M (1965) Hereditary absence of sebaceous glands in the mouse. Science 148:1471-3
50. Gearing AJ, Fincham NJ, Bird CR, Wadhwa M, Meager A, Cartwright JE et al. (1990) Cytokines in skin lesions of psoriasis. Cytokine 2:68-75
51. Gijbels MJ, Elliott GR, HogenEsch H, Zurcher C, van den Hoven A, Bruijnzeel PL (2000) Therapeutic interventions in mice with chronic proliferative dermatitis (cpdm/cpdm). Exp Dermatol 9:351-8
52. Gillum PS, Golitz LE (2004) Psoriasiform Dermatitis. In: Barnhill RL, Crowson AN (eds). Textbook of Dermatopathology. McGraw-Hill, New York, 61-78
53. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG (2000) NKT cells: facts, functions and fallacies. Immunol Today 21:573-83
54. Goldman JP, Blundell MP, Lopes L, Kinnon C, Di Santo JP, Thrasher AJ (1998) Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. Br J Haematol 103:335-42
55. Gordon KB, Bonish BK, Patel T, Leonardi CL, Nickoloff BJ (2005) The tumour necrosis factor-alpha inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaques. Br J Dermatol 153:945-53
56. Gorelik L, Flavell RA (2002) Transforming growth factor-beta in T-cell biology. Nat Rev Immunol 2:46-53
57. Goren I, Pfeilschifter J, Frank S (2003) Determination of leptin signaling pathways in human and murine keratinocytes. Biochem Biophys Res Commun 303:1080-5
58. Gorin NC, Piantadosi S, Stull M, Bonte H, Wingard JR, Civin C (2002) Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood. J Hematother Stem Cell Res 11:277-92
59. Greenhalgh DA, Rothnagel JA, Wang XJ, Quintanilla MI, Orengo CC, Gagne TA et al. (1993) Hyperplasia, hyperkeratosis and benign tumor production in transgenic mice by a targeted v-fos oncogene suggest a role for fos in epidermal differentiation and neoplasia. Oncogene 8:2145-57
60. Grose R, Hutter C, Bloch W, Thorey I, Watt FM, Fassler R et al. (2002) A crucial role of beta 1 integrins for keratinocyte migration in vitro and during cutaneous wound repair. Development 129:2303-15
61. Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT et al. (1989) Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86:6367-71
62. Groves RW, Mizutani H, Kieffer JD, Kupper TS (1995) Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis. Proc Natl Acad Sci USA 92:11874-8
63. Gudjonsson JE, Elder JT (2005) Mouse models: psoriasis: an epidermal disease after all? Eur J Hum Genet 14:2-4
64. Gudjonsson JE, Johnston A, Sigmundsdottir H, Valdimarsson H (2004) Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 135:1-8
65. Haase I, Hobbs RM, Romero MR, Broad S, Watt FM (2001) A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis. J Clin Invest 108:527-36
66. Hacquard-Bouder C, Ittah M, Breban M (2006) Animal models of HLA-B27-associated diseases: new outcomes. Joint Bone Spine 73:132-8
67. Haider AS, Duculan J, Whynot JA, Krueger JG (2006) Increased JunB mRNA and protein expression in psoriasis vulgaris lesions. J Invest Dermatol 126:912-4
68. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD (1990) Spontaneous inflammatory disease in transgenic rats expressing HLAB27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 63:1099-112
69. Hayden MS, Ghosh S (2004) Signaling to NF-kappaB. Genes Dev 18:2195-224
70. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L (1998) Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334(Part 2):297-314
71. Hernandez GL, Volpert OV, Iniguez MA, Lorenzo E, Martinez-Martinez S, Grau R et al. (2001) Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. J Exp Med 193:607-20
72. Hida S, Ogasawara K, Sato K, Abe M, Takayanagi H, Yokochi T et al. (2000) CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling. Immunity 13:643-55
73. Hirano T, Ishihara K, Hibi M (2000) Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19:2548-56
74. Hobbs RM, Silva-Vargas V, Groves R, Watt FM (2004) Expression of activated MEK1 in differentiating epidermal cells is sufficient to generate hyperproliferative and inflammatory skin lesions. J Invest Dermatol 123:503-15
75. HogenEsch H, Gijbels MJ, Offerman E, van Hooft J, van Bekkum DW, Zurcher C (1993) A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice. Am J Pathol 143:972-82
76. Hollnagel A, Oehlmann V, Heymer J, Ruther U, Nordheim A (1999) Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem 274:19838-45
77. Hong K, Chu A, Ludviksson BR, Berg EL, Ehrhardt RO (1999) IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder. J Immunol 162:7480-91
78. Hynes RO (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11-25
79. Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110:673-87
80. Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G et al. (2005) Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 106:1565-73
81. James LC, Moore AM, Wheeler LA, Murphy GM, Dowd PM, Greaves MW (1991) Transforming growth factor alpha: in vivo release by normal human skin following UV irradiation and abrasion. Skin Pharmacol 4:61-4
82. Jameson JM, Sharp LL, Witherden DA, Havran WL (2004) Regulation of skin cell homeostasis by gamma delta T cells. Front Biosci 9:2640-51
83. Jochum W, Passegue E, Wagner EF (2001) AP-1 in mouse development and tumorigenesis. Oncogene 20:2401-12
84. Johansen C, Flindt E, Kragballe K, Henningsen J, Westergaard M, Kristiansen K et al. (2005) Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin. J Invest Dermatol 124:1284-92
85. Johansen C, Kragballe K, Rasmussen M, Dam TN, Iversen L (2004) Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin. Br J Dermatol 151:600-7
86. Johnston A, Gudjonsson JE, Sigmundsdottir H, Love TJ, Valdimarsson H (2004) Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8(+) T cells. Clin Exp Immunol 138:83-93
87. Jonk LJ, Itoh S, Heldin CH, ten Dijke P, Kruijer W (1998) Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem 273:21145-52
88. Kamel-Reid S, Dick JE (1988) Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 242:1706-9
89. Kamezaki K, Shimoda K, Numata A, Haro T, Kakumitsu H, Yoshie M et al. (2005) Roles of Stat3 and ERK in G-CSF signaling. Stem Cells 23:252-63
90. Kane C, Hanawalt P, Knapp A, Mansbridge J (1989) Immunohistochemical localization of transforming growth factor-beta protein in psoriasis. J Invest Dermatol 92:455A
91. Kess D, Peters T, Zamek J, Wickenhauser C, Tawadros S, Loser K et al. (2003) CD4+ T cell-associated pathophysiology critically depends on CD18 gene dose effects in a murine model of psoriasis. J Immunol 171:5697-706
92. Khare SD, Hansen J, Luthra HS, David CS (1996) HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2 m) double transgenic mice with disrupted mouse beta2m. J Clin Invest 98:2746-55
93. Khare SD, Luthra HS, David CS (1995) Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies. J Exp Med 182:1153-8
94. Khavari PA (2006) Modelling cancer in human skin tissue. Nat Rev Cancer 6:270-80
95. Kopp T, Kieffer JD, Rot A, Strommer S, Stingl G, Kupper TS (2001) Inflammatory skin disease in K14/p40 transgenic mice: evidence for interleukin-12-like activities of p40. J Invest Dermatol 117:618-26
96. Kopp T, Lenz P, Bello-Fernandez C, Kastelein RA, Kupper TS, Stingl G (2003) IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity. J Immunol 170:5438-44
97. Kretzschmar M, Massague J (1998) SMADs: mediators and regulators of TGFbeta signaling. Curr Opin Genet Dev 8:103-11
98. Krueger GG, Chambers DA, Shelby J (1981) Involved and uninvolved skin from psoriatic subjects: are they equally diseased? Assessment by skin transplanted to congenitally athymic (nude) mice. J Clin Invest 68:1548-57
99. Kulski JK, Kenworthy W, Bellgard M, Taplin R, Okamoto K, Oka A et al. (2005) Gene expression profiling of Japanese psoriatic skin reveals an increased activity in molecular stress and immune response signals. J Mol Med 83:964-75
100. Kunstfeld R, Hirakawa S, Hong YK, Schacht V, Lange-Asschenfeldt B, Velasco P et al. (2004) Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. Blood 104:1048-57
101. Kuroda K, Sapadin A, Shoji T, Fleischmajer R, Lebwohl M (2001) Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. J Invest Dermatol 116:713-20
102. Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ (2004) IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 202:96-105
103. Lehmann J, Huehn J, De la Rosa M, Maszyna F, Kretschmer U, Krenn V et al. (2002) Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells. Proc Natl Acad Sci USA 99:13031-6
104. Leonard WJ, O'Shea JJ (1998) Jaks and STATs: biological implications. Annu Rev Immunol 16:293-322
105. Leonardi CL, Powers JL, Matheson RT, Goffe BS, Zitnik R, Wang A et al. (2003) Etanercept as monotherapy in patients with psoriasis. N Engl J Med 349:2014-22
106. Levy DE, Darnell JE Jr (2002) Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3:651-62
107. Levy L, Broad S, Diekmann D, Evans RD, Watt FM (2000) beta1 integrins regulate keratinocyte adhesion and differentiation by distinct mechanisms. Mol Biol Cell 11:453-66
108. Li AG, Wang D, Feng XH, Wang XJ (2004) Latent TGF-beta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. EMBO J 23:1770-81
109. Li Q, Lu Q, Hwang JY, Buscher D, Lee KF, Izpisua-Belmonte JC et al. (1999) IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev 13:1322-8
110. Liu X, Alexander V, Vijayachandra K, Bhogte E, Diamond I, Glick A (2001) Conditional epidermal expression of TGF-beta 1 blocks neonatal lethality but causes a reversible hyperplasia and alopecia. Proc Natl Acad Sci USA 98:9139-44
111. Logunova NN, Viret C, Pobezinsky LA, Miller SA, Kazansky DB, Sundberg JP et al. (2005) Restricted MHC-peptide repertoire predisposes to auto-immunity. J Exp Med 202:73-84
112. Lowe NJ, Breeding J, Kean C, Cohn ML (1981) Psoriasiform dermatosis in a rhesus monkey. J Invest Dermatol 76:141-3
113. Mansbridge JN, Knapp AM, Strefling AM (1984) Evidence for an alternative pathway of keratinocyte maturation in psoriasis from an antigen found in psoriatic but not normal epidermis. J Invest Dermatol 83:296-301
114. Matsuda H, Koyama H, Sato H, Sawada J, Itakura A, Tanaka A et al. (1998) Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing-impaired diabetic mice. J Exp Med 187:297-306
115. Mehic D, Bakiri L, Ghannadan M, Wagner EF, Tschachler E (2005) Fos and jun proteins are specifically expressed during differentiation of human keratinocytes. J Invest Dermatol 124:212-20
116. Meyerrose TE, Herrbrich P, Hess DA, Nolta JA (2003) Immune-deficient mouse models for analysis of human stem cells. Biotechniques 35:1262-72
117. Miura H, Sano S, Higashiyama M, Yoshikawa K, Itami S (2000) Involvement of insulin-like growth factor-I in psoriasis as a paracrine growth factor: dermal fibroblasts play a regulatory role in developing psoriatic lesions. Arch Dermatol Res 292:590-7
118. Miyazono K, Kusanagi K, Inoue H (2001) Divergence and convergence of TGF-beta/BMP signaling. J Cell Physiol 187:265-76
119. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE (1992) RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869-77
120. Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O et al. (2005) Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 202:135-43
121. Nickoloff BJ (2004) The skin cancer paradox of psoriasis: a matter of life and death decisions in the epidermis. Arch Dermatol 140:873-5
122. Nickoloff BJ, Kunkel SL, Burdick M, Strieter RM (1995) Severe combined immunodeficiency mouse and human psoriatic skin chimeras. Validation of a new animal model. Am J Pathol 146:580-8
123. Nickoloff BJ (2006) Psoriatic animal model validation index. J Invest Dermatol 126 (Suppl):59 (abstract)
124. Ohta Y, Katayama I, Funato T, Yokozeki H, Nishiyama S, Hirano T et al. (1991) In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions. Arch Dermatol Res 283:351-6
125. Pasparakis M, Courtois G, Hafner M, Schmidt-Supprian M, Nenci A, Toksoy A et al. (2002) TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417:861-6
126. Pellegrini G, De Luca M, Orecchia G, Balzac F, Cremona O, Savoia P et al. (1992) Expression, topography, and function of integrin receptors are severely altered in keratinocytes from involved and uninvolved psoriatic skin. J Clin Invest 89:1783-95
127. Piepkorn M (1996) Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin diseases. Am J Dermatopathol 18:165-71
128. Pincelli C (2000) Nerve growth factor and keratinocytes: a role in psoriasis. Eur J Dermatol 10:85-90
129. Pincelli C, Marconi A (2000) Autocrine nerve growth factor in human keratinocytes. J Dermatol Sci 22:71-9
130. Prinz JC, Gross B, Vollmer S, Trommler P, Strobel I, Meurer M et al. (1994) T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products. Eur J Immunol 24:593-8
131. Quddus J, Kaplan A, Richardson BC (1994) Anti-CD11a prevents deletion of self-reactive T cells in neonatal C57BR mice. Immunology 82:301-5
132. Raychaudhuri SP, Dutt S, Raychaudhuri SK, Sanyal M, Farber EM (2001) Severe combined immunodeficiency mouse-human skin chimeras: a unique animal model for the study of psoriasis and cutaneous inflammation. Br J Dermatol 144:931-9
133. Raychaudhuri SP, Sanyal M, Weltman H, Kundu-Raychaudhuri S (2004) K252a, a high-affinity nerve growth factor receptor blocker, improves psoriasis: an in vivo study using the severe combined immunodeficient mouse-human skin model. J Invest Dermatol 122:812-9
134. Rico L, Del Rio M, Bravo A, Ramirez A, Jorcano JL, Page MA et al. (2005) Targeted overexpression of leptin to keratinocytes in transgenic mice results in lack of skin phenotype but induction of early leptin resistance. Endocrinology 146:4167-76
135. Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K et al. (2005a) Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11:43-9
136. Sano S, Chan KS, Kira M, Kataoka K, Takagi S, Tarutani M et al. (2005b) Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation. Cancer Res 65:5720-9
137. Sano S, Itami S, Takeda K, Tarutani M, Yamaguchi Y, Miura H et al. (1999) Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J 18:4657-68
138. Sano S, Takeda J, Yoshikawa K, Itami S (2001) Tissue regeneration: hair follicle as a model. J Investig Dermatol Symp Proc 6:43-8
139. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M et al. (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70-4
140. Schon MP, Blume-Peytavi U, Schon M, Orfanos CE (1995) The human hair follicle: glycoprotein-related antigenic profile of distinct keratinocyte populations in vivo and their alterations in vitro. Arch Dermatol Res 287:591-8
141. Schon MP, Detmar M, Parker CM (1997) Murine psoriasis-like disorder induced by naive CD4+ T cells. Nat Med 3:183-8
142. Schon MP, Schon M, Warren HB, Donohue JP, Parker CM (2000) Cutaneous inflammatory disorder in integrin alphaE (CD103)-deficient mice. J Immunol 165:6583-9
143. Schuh AC, Keating SJ, Monteclaro FS, Vogt PK, Breitman ML (1990) Obligatory wounding requirement for tumorigenesis in v-jun transgenic mice. Nature 346:756-60
144. Sellheyer K, Bickenbach JR, Rothnagel JA, Bundman D, Longley MA, Krieg T et al. (1993) Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice. Proc Natl Acad Sci USA 90:5237-41
145. Shepherd J, Little MC, Nicklin MJ (2004) Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist. J Invest Dermatol 122:665-9
146. Shirakata Y, Kimura R, Nanba D, Iwamoto R, Tokumaru S, Morimoto C et al. (2005) Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J Cell Sci 118:2363-70
147. Shultz LD, Banuelos S, Lyons B, Samuels R, Burzenski L, Gott B et al. (2003) NOD/LtSz-Rag1nullPfpnull mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftment. Transplantation 76:1036-42
148. Shultz LD, Lang PA, Christianson SW, Gott B, Lyons B, Umeda S et al. (2000) NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J Immunol 164:2496-507
149. Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S et al. (2005) Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174:6477-89
150. Sigmundsdottir H, Johnston A, Gudjonsson JE, Valdimarsson H (2004) Differential effects of interleukin 12 and interleukin 10 on superantigen-induced expression of cutaneous lymphocyte-associated antigen (CLA) and alphaEbeta7 integrin (CD103) by CD8+ T cells. Clin Immunol 111:119-25
151. Sligh JE Jr, Ballantyne CM, Rich SS, Hawkins HK, Smith CW, Bradley A et al. (1993) Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci USA 90:8529-33
152. Song JI, Grandis JR (2000) STAT signaling in head and neck cancer. Oncogene 19:2489-95
153. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-14
154. Sriuranpong V, Park JI, Amornphimoltham P, Patel V, Nelkin BD, Gutkind JS (2003) Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system. Cancer Res 63:2948-56
155. Stoll S, Garner W, Elder J (1997) Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation In skin organ culture. J Clin Invest 100:1271-81
156. Stoll SW, Elder JT (1998) Retinoid regulation of heparin-binding EGF-like growth factor gene expression in human keratinocytes and skin. Exp Dermatol 7:391-7
157. Stratis A, Pasparakis M, Rupec RA, Markur D, Hartmann K, Scharffetter-Kochanek K et al. (2006) Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. J Clin Invest 116:2094-104
158. Sugai J, Iizuka M, Kawakubo Y, Ozawa A, Ohkido M, Ueyama Y et al. (1998) Histological and immunocytochemical studies of human psoriatic lesions transplanted onto SCID mice. J Dermatol Sci 17:85-92
159. Sundberg JP (1994) Handbook of Mouse Mutations With Skin and Hair Abnormalities. CRC Press: Boca Raton
160. Sundberg JP, Beamer WG, Shultz LD, Dunstan RW (1990) Inherited mouse mutations as models of human adnexal, cornification, and papulosquamous dermatoses. J Invest Dermatol 95:62S-3S
161. Sundberg JP, Boggess D, Schultz LD, Beamer WG (1994) The flaky skin (fsn) mutation, chromsome ?. In: Sundberg JP (ed). Handbook of Mouse Mutatins with Skin and Hair Abnormalities. CRC Press: Boca Raton, FL
162. Sundberg JP, King LE Jr (1996) Mouse mutations as animal models and biomedical tools for dermatological research. J Invest Dermatol 106:368-76
163. Szabowski A, Maas-Szabowski N, Andrecht S, Kolbus A, Schorpp-Kistner M, Fusenig NE et al. (2000) c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell 103:745-55
164. Takahashi A, Asakawa I, Yuki K, Matsumoto T, Kumamoto M, Kondo N et al. (2002) Radiation-induced apoptosis in the scid mouse spleen after low dose-rate irradiation. Int J Radiat Biol 78:689-93
165. Takizawa Y, Saida T, Tokuda Y, Dohi S, Ikegawa S, Ueyama Y (1995) Engraftment of precursor lesions of human cutaneous neoplasms onto C.B-17 SCID mice: a useful in vivo experimental model of carcinogenesis in human skin. Arch Dermatol Res 287:237-41
166. Takizawa Y, Saida T, Tokuda Y, Dohi S, Wang YL, Urano K et al. (1997) New immunodeficient (nude-scid, beige-scid) mice as excellent recipients of human skin grafts containing intraepidermal neoplasms. Arch Dermatol Res 289:213-8
167. Trinchieri G (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13:251-76
168. Turksen K, Kupper T, Degenstein L, Williams I, Fuchs E (1992) Interleukin
169. Turkson J, Jove R (2000) STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 19:6613-26
170. Ueyama T, Kawashima S, Sakoda T, Hirata K, Ohashi Y, Yamochi W et al. (1998) Transforming growth factor-beta1 and protein kinase C synergistically activate the c-fos serum response element in myocardial cells. J Mol Cell Cardiol 30:551-62
171. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ (1993) The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 101:701-5
172. Vallat VP, Gilleaudeau P, Battat L, Wolfe J, Nabeya R, Heftler N et al. (1994) PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy. J Exp Med 180:283-96
173. Vassar R, Fuchs E (1991) Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation. Genes Dev 5:714-27
174. Villadsen LS, Schuurman J, Beurskens F, Dam TN, Dagnaes-Hansen F, Skov L et al. (2003) Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. J Clin Invest 112:1571-80
175. Voskas D, Jones N, Van Slyke P, Sturk C, Chang W, Haninec A et al. (2005) A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice. Am J Pathol 166:843-55
176. Wach S, Schirmacher P, Protschka M, Blessing M (2001) Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos/jun family members. Oncogene 20:7761-9
177. Wang H, Peters T, Kess D, Sindrilaru A, Oreshkova T, Van Rooijen N et al. (2006) Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J Clin Invest 116:2105-14
178. Wang XJ, Liefer KM, Tsai S, O'Malley BW, Roop DR (1999) Development of gene-switch transgenic mice that inducibly express transforming growth factor beta1 in the epidermis. Proc Natl Acad Sci USA 96:8483-8
179. Watt FM (2002) Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J 21:3919-26
180. Weitzman JB (2001) Life and death in the jungle. Trends Mol Med 7:141-2
181. Wilgus TA, Matthies AM, Radek KA, Dovi JV, Burns AL, Shankar R et al. (2005) Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes. Am J Pathol 167:1257-66
182. Wilkinson DI, Karasek MA (1966) Skin lipids of a normal and mutant (asebic) mouse strain. J Invest Dermatol 47:449-55
183. Wrone-Smith T, Nickoloff BJ (1996) Dermal injection of immunocytes induces psoriasis. J Clin Invest 98:1878-87
184. Xia YP, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS (2003) Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 102:161-8
185. Yu G, Xu X, Vu MD, Kilpatrick ED, Li XC (2006) NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med 203:1851-8
186. Zanolli MD, Jayo MJ, Jayo JM, Blaine D, Hall J, Jorizzo JL (1989) Evaluation of psoriatic plaques that spontaneously developed in a cynomolgus monkey (Macaca fascicularis). Acta Derm Venereol Suppl (Stockholm) 146:58
187. Zenz R, Eferl R, Kenner L, Florin L, Hummerich L, Mehic D et al. (2005) Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437:369-75
188. Zheng Y, Eilertsen KJ, Ge L, Zhang L, Sundberg JP, Prouty SM et al. (1999) Scd1 is expressed in sebaceous glands and is disrupted in the asebia mouse. Nat Genet 23:268-70